IL13 and Parkinson disease: Additionally, the plasma level of IL-13 showed a marked increment in PD compared to the control group (12.49 ± 6.55 pg/ml vs. 2.93 ± 0.52 pg/ml, P < 0.01; by one-way ANOVA, Additional file 3).